US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Danielle Brill
Recent news which mentions Danielle Brill
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
October 10, 2024
Tickers
DNLI
NEWS
SNY
Tags
Health Care
Expert Ideas
SNY
From
Benzinga
Why This Biogen Analyst Is Turning Bullish On Alzheimer's Treatment Prospects
December 07, 2023
Tickers
BIIB
Tags
Benzinga
Analyst Color
Analyst Ratings
From
Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
September 28, 2022
Tickers
BIIB
Tags
Benzinga
BofA Securities
Price Target
From
Benzinga
What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict
July 14, 2021
Tickers
AZN
FGEN
Tags
Benzinga
AZN
News
From
Benzinga